CONNEQT Health Limited (ASX:CQT)

Australia · Delayed Price · Currency is AUD

0.0200

0.00 (0.00%)

At close: Aug 7, 2026

-37.50% (1Y)

Market Cap	18.11M +2.9%
Revenue (ttm)	5.80M +1.3%
Net Income	-17.21M
EPS	-0.04
Shares Out	905.43M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	113,149
Open	0.0190
Previous Close	0.0200
Day's Range	0.0190 - 0.0200
52-Week Range	0.0170 - 0.0640
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 22, 2026

About CONNEQT Health

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disord... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1994

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol CQT

Full Company Profile

Financial Performance

In fiscal year 2025, CONNEQT Health's revenue was 6.05 million, a decrease of -52.76% compared to the previous year's 12.81 million. Losses were -18.19 million, 168.9% more than in 2024.

Financial Statements